PharmaEngine Return on Equity

PharmaEngine (4162.TWO) currently reports a ROE of 10.97%. That is below the Healthcare sector average of 11.15%. Use the charts on this page to explore PharmaEngine's ROE history and peer comparisons.

PharmaEngine's ROE of 10.97% is lower than the Healthcare sector average of 11.15%. That is roughly 1.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but PharmaEngine's current 10.97% should be judged against Healthcare norms (sector average: 11.15%) and against 4162.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 10.97%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.15%. From there, open related valuation or income-statement pages for PharmaEngine, and consider following 4162.TWO for alerts when major investors trade the stock.

PharmaEngine is classified in the Healthcare sector. On ROE, it currently shows 10.97% versus a sector average near 11.15%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4162.TWO with unrelated industries.